Stay updated on Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.

Latest updates to the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2 appears on the page; no changes to study details, eligibility criteria, endpoints, or locations were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check23 days agoChange DetectedPublication description in the Publications From PubMed section was updated to read: 'These publications are automatically filled in from PubMed, a public database of scientific and medical articles, and may or may not be about the study.' The previous wording describing PubMed publications was replaced.SummaryDifference0.0%

- Check30 days agoChange Detected- Added Tainan, Taiwan, 70403 and removed Tainan City, Taiwan, 70403 from the study locations.SummaryDifference0.1%

- Check37 days agoChange DetectedIn Publications, the Meng et al. cost-effectiveness article is updated from an online ahead-of-print Oct 2025 version to the final December 2025 publication (J Med Econ).SummaryDifference0.0%

- Check66 days agoChange DetectedAdded a new scholarly citation on cost-effectiveness of enfortumab vedotin plus pembrolizumab for urothelial carcinoma, expanding the page's references with an authoritative source. No deletions were reported.SummaryDifference0.8%

- Check73 days agoChange DetectedUpdate includes a critical operating-status notice and an upgrade to version v3.2.0, indicating the page has moved to a new release and providing current operating-status details.SummaryDifference1%

Stay in the know with updates to Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.